Alexander Neumeister, MD, Associate Professor of Psychiatry at Mount Sinai School of Medicine, and colleagues collaborated with the Yale Positron Emission Tomography (PET) Center to evaluate 96 patients: 49 with PTSD; 20 who were exposed to trauma but did not have PTSD; and 27 healthy adults.
The patients were injected with a radiotracer, which is a substance that helps provide a clear picture of serotonin 1B levels. Then they underwent PET scans that produced advanced biological images of their brains. The patients were injected with a radiotracer, during the PET scan.
The researchers found that serotonin 1B levels were substantially lower in the group of patients diagnosed with PTSD than in patients who did not have PTSD, and slightly lower in the patients who had been exposed to trauma but did not have PTSD.
"Our research provides the first evidence of a novel mechanism in the brain, and sets the stage for the development of therapies that target serotonin 1B receptors, offering the potential to minimize the disabling effects of PTSD," said Dr. Neumeister. "Currently, the only medical treatment options for the nearly eight million American adults with PTSD are anti-depressants and anti-anxiety medications, which show little benefit in improving the mental health of these patients."
When Dr. Neumeister and his team evaluated predictors to explain the reduction in serotonin 1B levels in PTSD, they examined each patients' age, age at first traumatic experience, number of traumatic experiences, sex, body mass index and co-morbid depression, which is found frequently in PTSD. They found that it was the age at first trauma that determined the reduction in 1B receptors and the severity of PTSD, establishing that trauma at a young age causes long-lasting neurobiological and psychological effects in survivors with PTSD.
"The patients in our study included victims of childhood abuse, domestic violence, and military veterans," said Dr. Neumeister. "For these patients and the millions like them, treatment with currently available medications or psychotherapy is often ineffective. Unfortunately, people with PTSD often have additional psychiatric illnesses such as major depression or may develop substance use problems as an avenue for relieving their symptoms. Our research opens new doors in understanding PTSD and developing treatments for it, and may provide hope for these severely ill patients to be well."
The study was supported with funding from the National Institute of Mental Health, The Brain & Behavior Research Foundation (formerly NARSAD), and the VA National Center for PTSD.
Mount Sinai Press Office | EurekAlert!
Using fragment-based approaches to discover new antibiotics
21.06.2018 | SLAS (Society for Laboratory Automation and Screening)
Scientists learn more about how gene linked to autism affects brain
19.06.2018 | Cincinnati Children's Hospital Medical Center
In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.
Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
22.06.2018 | Materials Sciences
22.06.2018 | Earth Sciences
22.06.2018 | Life Sciences